Nektar Therapeutics (NKTR) Other Gross PP&E Adjustments (2016 - 2025)
Nektar Therapeutics (NKTR) has 16 years of Other Gross PP&E Adjustments data on record, last reported at -$7.2 million in Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments rose 20.0% year-over-year to -$7.2 million; the TTM value through Sep 2025 reached -$7.2 million, up 20.0%, while the annual FY2024 figure was -$28.3 million, 25.96% up from the prior year.
- Other Gross PP&E Adjustments reached -$7.2 million in Q3 2025 per NKTR's latest filing, up from -$7.6 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $12.5 million in Q3 2022 and bottomed at -$125.0 million in Q1 2021.
- Average Other Gross PP&E Adjustments over 5 years is -$46.6 million, with a median of -$29.5 million recorded in 2023.
- Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 110.43% in 2022, then plummeted 254.08% in 2023.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$60.2 million in 2021, then dropped by 29.67% to -$78.1 million in 2022, then skyrocketed by 51.08% to -$38.2 million in 2023, then grew by 25.96% to -$28.3 million in 2024, then soared by 74.64% to -$7.2 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$7.2 million in Q3 2025, -$7.6 million in Q2 2025, and -$8.0 million in Q1 2025.